Hepatic metastases from colorectal cancer;Prise en charge des patients ayant un cancer du foie: Les métastases hépatiques des cancers colorectaux

Bulletin du Cancer

Volumn 90, Issue 1, 2003, Pages 79-83

  Penna, Christophe ^a  

^a HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Colorectal cancer; Liver metastases; Radiofrequency; Surgery

Indexed keywords

FLOXURIDINE; FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CRYOTHERAPY; HUMAN; LIVER METASTASIS; LIVER RESECTION; PREOPERATIVE TREATMENT; PROGNOSIS; RADIOFREQUENCY; REVIEW; SURGICAL TECHNIQUE; SURVIVAL RATE; TISSUE INJURY; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR REGRESSION; TUMOR VOLUME;

CATHETER ABLATION; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; CRYOSURGERY; HEPATECTOMY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; SURVIVAL ANALYSIS;

EID: 17344395412     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 1994; 343: 1405-10.
2. Delva E, Camus Y, Nordlinger B, et al. Vascular occlusions for liver resections: operative management and tolerance to hepatic ischemia. Ann Surg 1989; 209: 211-8.
3. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991, 110: 13-29.
4. Nordlinger B, Jaeck D, Guiguet M, Vaillant JC, Balladur P, Schaal JC. Résection chirurgicale des métastases hépatiques. Enquête de l'Association française de chirurgie. In: Traitement des métastases hépatiques des cancers colorectaux. Springer-Verlag 1992, 141-159.
5. Hughes KS, Rosenbtein RB, Songhorabodi S, et al. Resection of liver for colorectal carcinoma metastases: a multi-institutional study of long term survivors. Dis Colon Rectum 1988; 31: 1-4.
6. Nordlinger B, Quilichini MA, Parc R, Hannoun L, Delva E, Huguet C. Hepatic resection for colorectal liver metastases: influence on survival of preoperative factors and surgery for recurrence in 80 patients. Ann Surg 1987; 205: 256-63.
7. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991; 110: 13-23.
8. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients. Cancer 1996; 77: 1254-62.
9. Fong Y, Cohen AM, Fottner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15: 938-46.
10. Nordlinger B, Vaillant JC, Guiguet, Balladut P, Patis F, Bachelier P, et al. Repeat liver resections for recurrent colorectal metastases: prolonged survivals. J Clin Oncol 1994; 12: 1491-96.
11. Lorenz M, Rossion I. Adjuvant and palliative regional therapy of liver metastases in colorectal tumors. Dtsch Med Wochenschr 1995; 120: 690-7.
12. Kemeny N, Huang Y, Cohen A, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999, 341: 2039-48.
13. Kemeny MM, Sudeshna A, Gray B, et al. Combined modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy: an intergroup study. J Clin Oncol 2002; 20: 1499-505.
14. Glimelius B, Hoffman K, Graf W, et al. Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer: the Nordic Gastrointestinal Tumor Adjuvant Therapy Group Cancer. Cancer 1994, 73: 556-62.
15. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial. Lancet 2000; 355: 1041-7.
16. De Gramont A, Figer A, Seymour M, et al. Leucovorin and Fluorouracil with or without oxaliplatin as first line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938-47.
17. Azoulay D, Castaing D, Smail A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 2000; 231: 480-6.
18. Elias D, de Baere T, Roche A, Bonvallot S, Lasser P. Preoperative selective portal vein embolizations are an effective means of extending the indications of major hepatectomy in the normal and injured liver. Hepatogastroenterol 1998; 45: 170-7.
19. Seifert JK. A collective review of the world literature on hepatic cryotherapy. JR Coll Surg Edinb 1998; 43: 141-54.
20. Seifert JK, Morris DL. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg 1998; 228: 201-8.
21. Scudamote CH, Lee SI, Patterson EJ, et al. Radiofrequency ablation followed by resection of malignant liver tumors. Am J Surg 1999; 177: 411-7.
22. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999; 230: 3-8.
23. Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long term results of a prospective randomized trial. J Clin Oncol 1992; 10: 1112-8.
24. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994; 344: 1255-60.
25. Bismuth H, Adam R, Lévi F, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996, 224: 509-22.